DUCENTIS BIOTHERAPEUTICS LTD has a total of 16 patent applications. It decreased the IP activity by 80.0%. Its first patent ever was published in 2016. It filed its patents most often in United Kingdom, Australia and Brazil. Its main competitors in its focus markets biotechnology and pharmaceuticals are SAPIENCE THERAPEUTICS INC, PROCELL THERAPEUTICS INC and INNOVATIVE CELLULAR THERAPEUTICS CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United Kingdom | 4 | |
#2 | Australia | 1 | |
#3 | Brazil | 1 | |
#4 | Canada | 1 | |
#5 | China | 1 | |
#6 | EPO (European Patent Office) | 1 | |
#7 | Israel | 1 | |
#8 | Republic of Korea | 1 | |
#9 | Mexico | 1 | |
#10 | Singapore | 1 | |
#11 | United States | 1 | |
#12 | WIPO (World Intellectual Property Organization) | 1 | |
#13 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Microorganisms | |
#3 | Medical preparations | |
#4 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Heal Jonathan | 9 |
#2 | Sheridan Joseph | 9 |
#3 | Huxley Philip | 9 |
#4 | Jonathan Heal | 2 |
#5 | Philip Huxley | 2 |
#6 | Joseph Sheridan | 2 |
Publication | Filing date | Title |
---|---|---|
GB202017506D0 | Novel proteins | |
GB201913320D0 | Novel proteins | |
GB201904756D0 | Novel proteins | |
GB201608197D0 | Novel proteins |